Kinnate Biopharma Inc.
KNTEDelisted Apr 3, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001797768
Kinnate Biopharma Inc. was delisted on Apr 3, 2024; its insiders filed their last Form 4 on Apr 5, 2024; 56 institutions reported holding it in 13F filings for Q1 2024, worth $92.2M in total; Viking Global Investors was the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Kinnate Biopharma Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 62
- 0 vs. Q1 2021
- Shares held
- 38.3M
- +456.4K (+1.2%) vs. Q1 2021
- Total value
- $890.9M
- −$286.1M (−24.3%) vs. Q1 2021
- New holders
- 9
- 17 more added
- Sold out
- 9
- 20 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KNTE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 56 | $92.2M |
| Q4 2023 | 62 | $91.0M |
| Q3 2023 | 59 | $54.0M |
| Q2 2023 | 72 | $121.4M |
| Q1 2023 | 71 | $270.4M |
| Q4 2022 | 79 | $249.0M |
| Q3 2022 | 84 | $520.8M |
| Q2 2022 | 73 | $543.5M |
| Q1 2022 | 76 | $464.9M |
| Q4 2021 | 71 | $750.5M |
| Q3 2021 | 74 | $905.1M |
| Q2 2021 | 62 | $890.9M |
| Q1 2021 | 62 | $1.18B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Kinnate Biopharma Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $225.2M | 30.43% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,847,929 | $89.6M | 0.92% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,593,052 | $83.6M | 1.34% | 00.0% | Unchanged |
| Vida Ventures Advisors, LLC | 2,747,433 | $64.0M | 16.04% | 00.0% | Unchanged |
| FMR LLC | 2,105,021 | $49.0M | 0.00% | −26,627−1.2% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,820,462 | $42.4M | 0.13% | −51,561−2.8% | Reduced |
| VR Adviser, LLC | 1,473,014 | $34.3M | 4.16% | 00.0% | Unchanged |
| Logos Global Management LP | 1,329,602 | $31.0M | 2.65% | +395,000+42.3% | Added |
| Citadel Advisors LLC | 1,300,887 | $30.3M | 0.03% | −14,763−1.1% | Reduced |
| BlackRock Inc. | 1,273,529 | $29.6M | 0.00% | +63,331+5.2% | Added |
| Vanguard Group Inc | 1,188,830 | $27.7M | 0.00% | −117,091−9.0% | Reduced |
| Boxer Capital, LLC | 1,065,939 | $24.8M | 0.88% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1,020,000 | $23.7M | 0.42% | +675,000+195.7% | Added |
| Foresite Capital Management V, LLC | 875,001 | $20.4M | 8.01% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 602,736 | $13.5M | 0.01% | −197,538−24.7% | Reduced |
| Harvard Management Co Inc | 498,001 | $11.6M | 0.67% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 445,477 | $10.4M | 0.00% | −203,305−31.3% | Reduced |
| Rock Springs Capital Management LP | 331,586 | $7.72M | 0.15% | +5,200+1.6% | Added |
| Federated Hermes, Inc. | 307,800 | $7.17M | 0.01% | 00.0% | Unchanged |
| Novo Holdings A/S | 300,000 | $6.98M | 0.31% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 264,293 | $6.15M | 0.20% | 00.0% | Unchanged |
| Woodline Partners LP | 260,276 | $6.06M | 0.11% | −25,853−9.0% | Reduced |
| Geode Capital Management, LLC | 237,249 | $5.52M | 0.00% | −1,332−0.6% | Reduced |
| State Street Corp | 237,130 | $5.52M | 0.00% | +53,848+29.4% | Added |
| Franklin Resources Inc | 192,100 | $4.47M | 0.00% | +17,093+9.8% | Added |
| American Century Companies Inc | 173,719 | $4.04M | 0.00% | +248+0.1% | Added |
| Northern Trust Corp | 135,513 | $3.15M | 0.00% | −10,095−6.9% | Reduced |
| Deutsche Bank AG | 126,311 | $2.94M | 0.00% | +99,184+365.6% | Added |
| Artal Group S.A. | 125,000 | $2.91M | 0.07% | 00.0% | Unchanged |
| Victory Capital Management Inc | 96,040 | $2.24M | 0.00% | −6,370−6.2% | Reduced |
| Charles Schwab Investment Management Inc | 90,050 | $2.10M | 0.00% | +1,409+1.6% | Added |
| Morgan Stanley | 87,053 | $2.03M | 0.00% | +87,053 | New |
| Nuveen Asset Management, LLC | 57,743 | $1.34M | 0.00% | +8,557+17.4% | Added |
| DAFNA Capital Management LLC | 54,415 | $1.27M | 0.26% | +1,500+2.8% | Added |
| Bank of New York Mellon Corp | 40,723 | $948.0K | 0.00% | +4,957+13.9% | Added |
| Renaissance Technologies LLC | 35,900 | $836.0K | 0.00% | +35,900 | New |
| TD Asset Management Inc | 37,407 | $807.0K | 0.00% | −7,300−16.3% | Reduced |
| HighVista Strategies LLC | 33,391 | $777.0K | 0.55% | +33,391 | New |
| EcoR1 Capital, LLC | 25,000 | $582.0K | 0.02% | 00.0% | Unchanged |
| Swiss National Bank | 24,000 | $559.0K | 0.00% | +24,000 | New |
| D. E. Shaw & Co., Inc. | 20,757 | $483.0K | 0.00% | −2,088−9.1% | Reduced |
| HRT Financial LP | 20,213 | $470.0K | 0.00% | +20,213 | New |
| California State Teachers Retirement System | 18,707 | $435.0K | 0.00% | −1,678−8.2% | Reduced |
| Rhumbline Advisers | 15,455 | $360.0K | 0.00% | +3,758+32.1% | Added |
| Goldman Sachs Group Inc | 15,212 | $354.0K | 0.00% | −2,562−14.4% | Reduced |
| Ensign Peak Advisors, Inc | 15,000 | $349.0K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 13,272 | $309.0K | 0.00% | +13,272 | New |
| New York State Common Retirement Fund | 13,111 | $305.0K | 0.00% | +5,811+79.6% | Added |
| JPMorgan Chase & Co | 8,147 | $189.0K | 0.00% | +3,079+60.8% | Added |
| American International Group, Inc. | 7,598 | $177.0K | 0.00% | −279−3.5% | Reduced |
| Bank of America Corp | 5,263 | $123.0K | 0.00% | −21,919−80.6% | Reduced |
| STRS Ohio | 3,300 | $76.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,012 | $48.0K | 0.00% | +224+12.5% | Added |
| Citigroup Inc | 1,403 | $33.0K | 0.00% | +408+41.0% | Added |
| Legal & General Group Plc | 1,123 | $26.0K | 0.00% | −247−18.0% | Reduced |
| Ameritas Investment Partners, Inc. | 1,099 | $26.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 648 | $15.0K | 0.00% | −2−0.3% | Reduced |
| UBS Group AG | 252 | $6.00K | 0.00% | −536−68.0% | Reduced |
| Wells Fargo & Company | 139 | $3.00K | 0.00% | −4,077−96.7% | Reduced |
| US Bancorp | 50 | $1.00K | 0.00% | +50 | New |
| Signaturefd, LLC | 59 | $1.00K | 0.00% | +59 | New |
| TCI Wealth Advisors, Inc. | 19 | $0 | 0.00% | +19 | New |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −109,000−100.0% | Sold out |
| Parkwood LLC | 0 | $0 | 0.00% | −13,198−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −7,566−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −7,620−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −6,421−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −4,693−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −419−100.0% | Sold out |